We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Novel Device for Treatment of Anal Fistula Uses Single-Operation Approach to Prevent Multiple Surgeries

By HospiMedica International staff writers
Posted on 19 Sep 2023
Print article
Image: A clinical trial has evaluated the safety and efficacy of the BioHealx device for treatment of anal fistula (Photo courtesy of Signum Surgical)
Image: A clinical trial has evaluated the safety and efficacy of the BioHealx device for treatment of anal fistula (Photo courtesy of Signum Surgical)

An anal fistula is an artificial tunnel connecting the rectum to the skin near the buttocks, often caused by an infected or clogged anal gland. If it's not treated, the infection might lead to an abscess and could spread through the sphincter muscle. Existing treatments are not always effective and can result in slow healing, repeated procedures, and a heightened risk of incontinence. Now, a novel surgical device can treat this painful and debilitating colorectal condition which affects one in 5,000 people worldwide.

Signum Surgical (Galway, Ireland), in collaboration with expert colorectal surgeons, has developed BioHealx which enables surgeons to treat anal fistulas through a less invasive procedure done on an outpatient basis. The BioHealx system includes a one-time, bioabsorbable implant intended to seal the fistula tract and then naturally dissolve in the body. This one-step process aims to aid healing, lower the chances of fistula recurrence, and safeguard against incontinence.

Signum Surgical has completed up its single-arm, non-randomized clinical trial, which tested the safety and effectiveness of the BioHealx device in treating anal fistulas. Conducted across multiple centers and led by four expert investigators, the study involved 32 adult male and female patients who had recurrent anal fistulas following at least one previous unsuccessful treatment. These patients have been monitored for a period ranging from 13 to 40 months, and the final follow-up assessments have been completed.

The data gathered from this trial is in the process of being compiled for a De Novo classification submission to the U.S. Food and Drug Administration (FDA) and will be soon published in scientific journals. Given that BioHealx is an entirely new treatment with no existing counterpart on the market, Signum Surgical is filing a De Novo request for its classification. BioHealx offers potential as a promising surgical alternative for treating anal fistulas. It is especially noteworthy for its ease of use by medical professionals. This method could potentially eliminate the necessity for multiple surgeries, decrease surgical trauma, lower the recurrence rate of fistulas, and bring down both patient and healthcare system costs.

“The completion of our clinical trial marks a significant milestone for Signum Surgical and our BioHealx device,” said Moshe Zilversmit, Co-Founder and CEO of Signum Surgical. “We look forward to submitting our De Novo classification request to the U.S. FDA and the scientific publication of the data in due course, as we seek to bring this novel treatment to market for the benefit of patients, surgeons, and the healthcare system.”

Related Links:
Signum Surgical

Platinum Supplier
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Supplier
Temperature Monitor
ThermoScan Temperature Monitoring Unit
New
All-Lead ECG Workstation
Dixion 1018
New
Portable DR Flat Panel Detector
VIVIX-S 1012N

Print article
Radcal

Channels

Critical Care

view channel
Image: Flexible thin-film electrodes placed directly on brain tissue have shown promise for diagnosis and treatment of epilepsy (Photo courtesy of Tokyo Tech)

Thin-Film Neural Electrodes Placed Directly on Brain Tissue Can Diagnose and Treat Epilepsy

Analyzing brain activity is crucial for diagnosing conditions like epilepsy and other mental health disorders. Among various methods, electroencephalography (EEG) is considered the least intrusive, using... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The broad-spectrum POC coagulometer is well-suited for emergency room and emergency vehicle use (Photo courtesy of Perosphere)

Novel POC Coagulometer with Lab-Like Precision to Revolutionize Coagulation Testing

In emergency settings, when patients arrive with a bleed or require urgent surgery, doctors rely solely on clinical judgment to determine if a patient is adequately anticoagulated for reversal treatment.... Read more

Business

view channel
Image: The global surgical lights market is expected to grow by close to USD 0.50 billion from 2022 to 2027 (Photo courtesy of Freepik)

Global Surgical Lights Market Driven by Increasing Number of Procedures

The global surgical lights market is set to witness high growth, largely due to the increasing incidence of chronic illnesses, a surge in demand for cosmetic and plastic surgeries, and untapped opportunities... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.